Form 4 Filing: Muzzey Dale Acquires (Grant) shares of $MYGN

STOCK AWARD / GRANT

⚡ MATERIALITY: 1/10

corporate issuer

MYRIAD GENETICS INC

Ticker: $MYGN

Transaction Value

N/A (Non-Open-Market)

Price/Share: $0.00 (Non-Open-Market)

transaction date

2026-11-06

Shares: 92,632

Market Price Activity

HillSignal AI Analytical Report

SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Muzzey Dale, holds the title of Chief Scientific Officer at MYRIAD GENETICS INC.

On 2026-11-06, the insider transacted 92,632 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.

Executive Summary Summary

Muzzey Dale (Chief Scientific Officer) was granted $0 of $MYGN

Post-Transaction Position: 92,632 shares

SEC Accession No: 0001922964-26-000012 (CIK: 1922964)

Verified Multi-Source Index

Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.

SEC EDGAR FilingView Source Form 4

Yahoo Finance$MYGN Quote & Profile

OpenCorporates RegistryVerify Corporate Identity

Google News$MYGN News Coverage